A
Ozempic cannot “end” addiction, but Dhruv Khullar’s 2026 TED Talk argues that GLP‑1 drugs (like Ozempic, Wegovy, and semaglutide) may quiet cravings by acting on the brain’s reward pathways — offering a biological tool for moderation, not a cure.
🧠 What GLP‑1 drugs actually do
GLP‑1 medications were originally designed for diabetes and later weight loss, but research shows they also act on the mesolimbic reward system, dampening the dopamine spikes that drive cravings for alcohol, nicotine, opioids, and even behavioral addictions like gambling or compulsive shopping.
People often describe a reduction in “noise” — intrusive thoughts about food, alcohol, or other substances. In Khullar’s talk, the patient Mary said her “alcohol noise” simply vanished.
🔬 Evidence so far
Alcohol addiction: Some trial participants rapidly lose interest in alcohol; Mary stopped drinking within weeks.
Smoking: Smokers given exenatide were twice as likely to quit compared with placebo.
Opioids: People with opioid addiction who happened to be prescribed GLP‑1s were 40% less likely to overdose (correlational data).
Behavioral addictions: Early research suggests possible effects on gambling and compulsive shopping.
These findings suggest GLP‑1s may target a universal addiction pathway, not just substance-specific mechanisms.
⚠️ Why GLP‑1s are not a cure
Khullar emphasizes that GLP‑1s are not a magic bullet:
They can cause anhedonia — a dampening of desire so broad that people lose interest in many pleasurable activities.
Many patients stop due to side effects, cost, or tolerance. Cravings can return.
Addiction is multi-layered — trauma, environment, and emotional regulation still matter. Medication alone cannot rebuild a life.
Khullar frames GLP‑1s as “moderation molecules”: they create mental space so people can make different choices, but they don’t replace therapy, support systems, or long-term recovery work.
🧩 The takeaway
Ozempic doesn’t end addiction — but it may quiet cravings enough to help some people regain control. It’s a promising biological tool, not a standalone solution.
If you want, I can go deeper into:
how GLP‑1 drugs affect the brain
the risks of using Ozempic for addiction
the science behind dopamine and craving
other emerging addiction treatments
No comments:
Post a Comment